Mrs. Saraswati wani college of pharmacy ganegoan
3D printing technology has emerged as a transformative force in modern medicine, enabling the precise fabrication of customized drug formulations, medical devices, and implants. This review discusses the potential of 3D printing in personalized medicine, its current applications, and future perspectives. The advantages, technological advancements, regulatory challenges, and potential barriers to widespread adoption are also explored.
3D printing, or additive manufacturing, has gained significant traction in the pharmaceutical and biomedical fields. It allows for layer-by-layer fabrication of medical products with high precision and customization. This review aims to highlight the current status of 3D printing in medicine and explore its potential future impact on drug development, personalized therapy, and patient-specific healthcare solutions.
Current Applications of 3D Printing in Medicine
3D printing is currently used to create patient-specific implants, prosthetics, surgical tools, and drug dosage forms. Spritam®, the first FDA-approved 3D-printed drug, demonstrates the feasibility of this technology in pharmaceutical manufacturing. Hospitals and research centers are also leveraging 3D printing for anatomical models and surgical planning.
Advantages and Technological Innovations
3D printing enables tailored drug dosages, complex geometries, and multi-drug combinations in a single tablet. Technologies such as fused deposition modeling (FDM), stereolithography (SLA), and selective laser sintering (SLS) are being adapted for pharmaceutical applications, offering rapid prototyping and high material efficiency.
Challenges and Regulatory Considerations
Despite its promise, 3D printing in medicine faces challenges such as high costs, technical limitations, regulatory uncertainty, and scalability. Quality control, reproducibility, and material safety are critical issues that must be addressed before large-scale implementation.
Future Perspectives
The future of 3D printing in medicine is highly promising. Advancements in bioprinting may enable the creation of living tissues and organs. Personalized drug printing at pharmacies or hospitals could revolutionize treatment delivery. With ongoing research, improved regulation, and reduced costs, 3D printing is poised to become an integral part of future healthcare.
CONCLUSION
3D printing represents a revolutionary approach to healthcare, offering customized solutions and enhancing patient outcomes. While challenges remain, continued innovation and collaboration between technology developers, pharmaceutical companies, and regulatory bodies will pave the way for its successful integration into mainstream medicine.
REFERENCES
Vivek Ghadage, Implementation of 3D Printing in Medicine – Future Perspectives, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 5, 2418-2419. https://doi.org/10.5281/zenodo.15423875